Bicifadine
XTL B07-001
Phase 2 small_molecule active
Quick answer
Bicifadine for Diabetic Peripheral Neuropathy is a Phase 2 program (small_molecule) at XTL BIOPHARMACEUTICALS LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- XTL BIOPHARMACEUTICALS LTD
- Indication
- Diabetic Peripheral Neuropathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active